TrimRx's Blog

Mounjaro (tirzepatide) treats obesity through dual GIP/GLP-1 receptor activation, delivering 15–22% body weight reduction. How it works, who qualifies,

Mounjaro shows 59% NASH resolution vs 17% placebo in clinical trials — effects extend beyond weight loss through direct hepatic GLP-1 receptor activation.

Mounjaro targets prediabetes by activating GIP and GLP-1 receptors to improve insulin sensitivity and lower A1C below diagnostic thresholds.

Mounjaro shows 59% NASH resolution vs 17% placebo in clinical trials, with significant hepatic fat reduction beyond weight loss alone in NAFLD patients.

Mounjaro reduces blood pressure by 4–6 mmHg systolic in clinical trials through weight loss and improved insulin sensitivity, not direct vascular action.

The first time most people have to give themselves a tirzepatide injection, there is usually a moment of hesitation. You stare at the pen…

You finally start seeing progress on the scale, your appetite is calmer, and things feel like they are moving in the right direction. Then…

A few years ago, most people only heard about weight loss injections in passing. Now they are everywhere. Friends bring them up over dinner,…

Some women seem to lose weight just by cutting out soda for a week. Others spend months eating salads and walking every evening, yet…